Enanta Pharmaceuticals (ENTA) EPS (Basic) (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted EPS (Basic) of -$0.45 for Q1 2026, down 8.56% on a QoQ basis from -$0.42 in Q4 2025, and up 57.49% year-over-year from -$0.29 in Q1 2025.
Enanta Pharmaceuticals (ENTA) EPS (Basic) (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$0.45 for Q1 2026.
- Quarterly EPS (Basic) rose 57.49% year-over-year to -$0.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.13 (up 52.72% YoY) and the FY2025 annual result came in at -$3838.1, up 30.03% from the prior year.
- EPS (Basic) was -$0.45 for Q1 2026 at Enanta Pharmaceuticals, down from -$0.42 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.42 in Q4 2025 and bottomed at -$1362.3 in Q3 2024.
- A 5-year average of -$279.64 and a median of -$1.53 in 2022 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 68.5% in 2022, while the deepest fall reached 28.71% in 2022.
- Enanta Pharmaceuticals' EPS (Basic) stood at -$1.39 in 2022, then declined by 13.77% to -$1.58 in 2023, then surged by 33.75% to -$1.05 in 2024, then jumped by 60.43% to -$0.42 in 2025, then dropped by 8.56% to -$0.45 in 2026.
- Business Quant data shows ENTA's EPS (Basic) at -$0.45 in Q1 2026, -$0.42 in Q4 2025, and -$876.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -876.45 |
| Jun 30, 2025 | -0.85 |
| Mar 31, 2025 | -1.06 |
| Dec 31, 2024 | -1.05 |
| Sep 30, 2024 | -1,362.34 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.47 |
| Dec 31, 2023 | -1.58 |
| Sep 30, 2023 | -1,220.13 |
| Jun 30, 2023 | -1.86 |
| Mar 31, 2023 | -1.79 |
| Dec 31, 2022 | -1.39 |
| Sep 30, 2022 | -1,278.84 |
| Jun 30, 2022 | -1.53 |
| Mar 31, 2022 | -1.63 |
| Dec 31, 2021 | -1.48 |
| Sep 30, 2021 | -4,060.43 |
| Jun 30, 2021 | -1.19 |